Can CPHL dominate Pakistan’s growing antibiotic sector?
Key takeaways Pakistan’s antibiotic market is valued at Rs185 billion, growing 12% YoY in FY25. CPHL is set to launch four new antibiotics to tap into this...
Can Citi Pharma (CPHL) reach Rs. 217 in a year?
Citi Pharma (CPHL), one of Pakistan’s leading API producers, is gearing up for a major growth surge
Which segment will drive CPHL’s growth in next 3 years?
Pakistan’s pharmaceutical sector witnessed significant growth in FY24, driven by price deregulation and rising demand for essential medications.
CPHL plans to shift to solar power
Citi Pharma Limited (CPHL) announced that it embraces solar energy, pioneering a sustainable path.